Archives

by in
Entry Author Date Location
Verastem Switches CEOs as Westphal Steps Into Chairman Role 06/06/13 Boston
OvaScience, Founded by Sirtris Vets, Plans IPO 08/30/12 Boston
OvaScience Lands $37,000,000 Series B Financing 04/04/12 Boston
Verastem Bucks the Trend, Raises $55M in IPO 01/26/12 Boston
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO 11/03/11 Boston
OvaScience Uses Stem Cells to Revive Fertility 10/12/11 Boston
OvaScience Lands $6,000,000 Series A Round 10/11/11 Boston
BuyWithMe Gets Edhance, LogMeIn Picks Up Pachube, Polaris Backs Two MA Companies, & More Boston-Area Deals News 07/20/11 Boston
Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News 07/15/11 Boston
Verastem, Rooted at MIT, Raises $32 Million and Adds ATV and Astellas to Slate of Investors 07/14/11 Boston
Verastem Obtains $32,000,000 Series B Financing Round 07/14/11 Boston
Termeer Joins Verastem Board 06/13/11 Boston
SR One Opens Bay Area Shop 04/26/11 San Francisco
Westphal Leaving Glaxo, Cubist Settles Patent Litigation with Teva, BSX Buys S.I., & More Boston-Area Life Sciences News 04/08/11 Boston
Patients’ Parents Upset By FDA Panel’s Rejection of Lilly/Alnara’s Cystic Fibrosis Drug 01/19/11 Boston
Rich Aldrich, Biotech Powerbroker, Breaks Silence on New $87M Longwood Founders Fund 01/06/11 Boston
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News 11/19/10 Boston
Verastem, Founded by MIT Big Names, Raises $16M to Fight Cancer Stem Cells 11/16/10 Boston
Verastem Secures $16,000,000 Series A Round 11/16/10 Boston
Former Sirtris Execs’ Nonprofit Starts Selling Resveratrol with Potential Anti-Aging Effects Online 08/12/10 Boston
How Eli Lilly Let a Billion-Dollar Molecule Slip Away and Make a Fortune for Vertex 08/04/10 Boston
Eli Lilly Pays up to $380M for Alnara Pharma 07/20/10 Boston
Glaxo’s Tempero Pharma Advances on Hot Niche of Immunology 07/15/10 Boston
Alnara Pharma Used “Flexible” Strategy on Road to Eli Lilly Deal 07/08/10 Boston
Google Pays $700M for ITA, Eli Lilly Buys Alnara, Skyhook Lands Samsung Partnership, & More Boston-Area Deals News 07/07/10 Boston
Drug Giant Eli Lilly Buys Alnara Pharma To Get Cystic Fibrosis Drug 07/02/10 Boston
Glaxo’s SR One Injects Pharma Bucks into $22M Round for Constellation Pharma 06/02/10 Boston
Sirtris Vet Michelle Dipp Takes Over Key Role at Glaxo as Westphal Returns to VC 04/22/10 Boston
Sirtris Founders Resurface with New Fund, Icahn Continues to Make Biotech Waves, Sentillion Bought by Microsoft, & More Boston-Area Life Sciences News 02/19/10 Boston
Sirtris Founders Build New Venture Capital Fund, Keep Mum 02/12/10 Boston
Page 1 of 1

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.